Effect of highly active antiretroviral therapy on viral burden in the lungs of HIV-infected subjects

Homer Twigg, Michael Weiden, Fred Valentine, Carol T. Schnizlein-Bick, Roland Bassett, Lu Zheng, Joseph Wheat, Richard B. Day, Helen Rominger, Ronald G. Collman, Lawrence Fox, Barbara Brizz, Joan Dragavon, Robert W. Coombs, R. Pat Bucy

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Background. Human immunodeficiency virus (HIV) is readily detectable in the lungs of infected subjects and leads to an accumulation of CD8+ lymphocytes in the alveolar space. Although highly active antiretroviral therapy (HAART) is effective in reducing viremia, less is known about its effect on tissue compartments. The AIDS Clinical Trials Group Protocol 723 Team evaluated the effect of HAART on lung viral load and cellular constituents. Methods. Bronchoalveolar lavage (BAL) fluid and blood were collected before initiation of HAART and again at 4 and 24 weeks after initiation of therapy. The BAL cell differential was determined, lymphocyte phenotyping was performed, and acellular BAL fluid, plasma HIV RNA load, and BAL cell and peripheral blood mononuclear cell HIV RNA and DNA loads were measured. Results. HAART induced a rapid decrease in HIV that was detectable in acellular BAL fluid and a slower decrease in the HIV RNA and DNA loads in BAL cells. HAART was associated with a significant decrease in the absolute number and percentage of CD8+ alveolar lymphocytes. There was a significant correlation between residual BAL cell DNA at 24 weeks and the absolute number of CD4+ lymphocytes in the alveolar space. Conclusion. HAART is associated with a significant decrease in the pulmonary HIV burden and a return of alveolar cellular constituents to normal.

Original languageEnglish
Pages (from-to)109-116
Number of pages8
JournalJournal of Infectious Diseases
Volume197
Issue number1
DOIs
StatePublished - Jan 1 2008

Fingerprint

Highly Active Antiretroviral Therapy
Viral Load
HIV
Bronchoalveolar Lavage
Lung
Bronchoalveolar Lavage Fluid
RNA
DNA
Lymphocytes
Immunophenotyping
Viremia
Lymphocyte Count
Clinical Protocols
Blood Cells
Acquired Immunodeficiency Syndrome
Clinical Trials

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Immunology

Cite this

Twigg, H., Weiden, M., Valentine, F., Schnizlein-Bick, C. T., Bassett, R., Zheng, L., ... Bucy, R. P. (2008). Effect of highly active antiretroviral therapy on viral burden in the lungs of HIV-infected subjects. Journal of Infectious Diseases, 197(1), 109-116. https://doi.org/10.1086/523766

Effect of highly active antiretroviral therapy on viral burden in the lungs of HIV-infected subjects. / Twigg, Homer; Weiden, Michael; Valentine, Fred; Schnizlein-Bick, Carol T.; Bassett, Roland; Zheng, Lu; Wheat, Joseph; Day, Richard B.; Rominger, Helen; Collman, Ronald G.; Fox, Lawrence; Brizz, Barbara; Dragavon, Joan; Coombs, Robert W.; Bucy, R. Pat.

In: Journal of Infectious Diseases, Vol. 197, No. 1, 01.01.2008, p. 109-116.

Research output: Contribution to journalArticle

Twigg, H, Weiden, M, Valentine, F, Schnizlein-Bick, CT, Bassett, R, Zheng, L, Wheat, J, Day, RB, Rominger, H, Collman, RG, Fox, L, Brizz, B, Dragavon, J, Coombs, RW & Bucy, RP 2008, 'Effect of highly active antiretroviral therapy on viral burden in the lungs of HIV-infected subjects', Journal of Infectious Diseases, vol. 197, no. 1, pp. 109-116. https://doi.org/10.1086/523766
Twigg, Homer ; Weiden, Michael ; Valentine, Fred ; Schnizlein-Bick, Carol T. ; Bassett, Roland ; Zheng, Lu ; Wheat, Joseph ; Day, Richard B. ; Rominger, Helen ; Collman, Ronald G. ; Fox, Lawrence ; Brizz, Barbara ; Dragavon, Joan ; Coombs, Robert W. ; Bucy, R. Pat. / Effect of highly active antiretroviral therapy on viral burden in the lungs of HIV-infected subjects. In: Journal of Infectious Diseases. 2008 ; Vol. 197, No. 1. pp. 109-116.
@article{76bf08449ea84d79b3948a0f8e388204,
title = "Effect of highly active antiretroviral therapy on viral burden in the lungs of HIV-infected subjects",
abstract = "Background. Human immunodeficiency virus (HIV) is readily detectable in the lungs of infected subjects and leads to an accumulation of CD8+ lymphocytes in the alveolar space. Although highly active antiretroviral therapy (HAART) is effective in reducing viremia, less is known about its effect on tissue compartments. The AIDS Clinical Trials Group Protocol 723 Team evaluated the effect of HAART on lung viral load and cellular constituents. Methods. Bronchoalveolar lavage (BAL) fluid and blood were collected before initiation of HAART and again at 4 and 24 weeks after initiation of therapy. The BAL cell differential was determined, lymphocyte phenotyping was performed, and acellular BAL fluid, plasma HIV RNA load, and BAL cell and peripheral blood mononuclear cell HIV RNA and DNA loads were measured. Results. HAART induced a rapid decrease in HIV that was detectable in acellular BAL fluid and a slower decrease in the HIV RNA and DNA loads in BAL cells. HAART was associated with a significant decrease in the absolute number and percentage of CD8+ alveolar lymphocytes. There was a significant correlation between residual BAL cell DNA at 24 weeks and the absolute number of CD4+ lymphocytes in the alveolar space. Conclusion. HAART is associated with a significant decrease in the pulmonary HIV burden and a return of alveolar cellular constituents to normal.",
author = "Homer Twigg and Michael Weiden and Fred Valentine and Schnizlein-Bick, {Carol T.} and Roland Bassett and Lu Zheng and Joseph Wheat and Day, {Richard B.} and Helen Rominger and Collman, {Ronald G.} and Lawrence Fox and Barbara Brizz and Joan Dragavon and Coombs, {Robert W.} and Bucy, {R. Pat}",
year = "2008",
month = "1",
day = "1",
doi = "10.1086/523766",
language = "English",
volume = "197",
pages = "109--116",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Effect of highly active antiretroviral therapy on viral burden in the lungs of HIV-infected subjects

AU - Twigg, Homer

AU - Weiden, Michael

AU - Valentine, Fred

AU - Schnizlein-Bick, Carol T.

AU - Bassett, Roland

AU - Zheng, Lu

AU - Wheat, Joseph

AU - Day, Richard B.

AU - Rominger, Helen

AU - Collman, Ronald G.

AU - Fox, Lawrence

AU - Brizz, Barbara

AU - Dragavon, Joan

AU - Coombs, Robert W.

AU - Bucy, R. Pat

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Background. Human immunodeficiency virus (HIV) is readily detectable in the lungs of infected subjects and leads to an accumulation of CD8+ lymphocytes in the alveolar space. Although highly active antiretroviral therapy (HAART) is effective in reducing viremia, less is known about its effect on tissue compartments. The AIDS Clinical Trials Group Protocol 723 Team evaluated the effect of HAART on lung viral load and cellular constituents. Methods. Bronchoalveolar lavage (BAL) fluid and blood were collected before initiation of HAART and again at 4 and 24 weeks after initiation of therapy. The BAL cell differential was determined, lymphocyte phenotyping was performed, and acellular BAL fluid, plasma HIV RNA load, and BAL cell and peripheral blood mononuclear cell HIV RNA and DNA loads were measured. Results. HAART induced a rapid decrease in HIV that was detectable in acellular BAL fluid and a slower decrease in the HIV RNA and DNA loads in BAL cells. HAART was associated with a significant decrease in the absolute number and percentage of CD8+ alveolar lymphocytes. There was a significant correlation between residual BAL cell DNA at 24 weeks and the absolute number of CD4+ lymphocytes in the alveolar space. Conclusion. HAART is associated with a significant decrease in the pulmonary HIV burden and a return of alveolar cellular constituents to normal.

AB - Background. Human immunodeficiency virus (HIV) is readily detectable in the lungs of infected subjects and leads to an accumulation of CD8+ lymphocytes in the alveolar space. Although highly active antiretroviral therapy (HAART) is effective in reducing viremia, less is known about its effect on tissue compartments. The AIDS Clinical Trials Group Protocol 723 Team evaluated the effect of HAART on lung viral load and cellular constituents. Methods. Bronchoalveolar lavage (BAL) fluid and blood were collected before initiation of HAART and again at 4 and 24 weeks after initiation of therapy. The BAL cell differential was determined, lymphocyte phenotyping was performed, and acellular BAL fluid, plasma HIV RNA load, and BAL cell and peripheral blood mononuclear cell HIV RNA and DNA loads were measured. Results. HAART induced a rapid decrease in HIV that was detectable in acellular BAL fluid and a slower decrease in the HIV RNA and DNA loads in BAL cells. HAART was associated with a significant decrease in the absolute number and percentage of CD8+ alveolar lymphocytes. There was a significant correlation between residual BAL cell DNA at 24 weeks and the absolute number of CD4+ lymphocytes in the alveolar space. Conclusion. HAART is associated with a significant decrease in the pulmonary HIV burden and a return of alveolar cellular constituents to normal.

UR - http://www.scopus.com/inward/record.url?scp=39349088338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39349088338&partnerID=8YFLogxK

U2 - 10.1086/523766

DO - 10.1086/523766

M3 - Article

VL - 197

SP - 109

EP - 116

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 1

ER -